{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:56:35Z","timestamp":1792806995946,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"BITS Pilani Hyderabad campus- La Trobe ASCRIN PhD Scholarship"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-28304-y","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T05:36:30Z","timestamp":1764567390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular modeling to simulation: insights into Gaussian QSAR, molecular docking, and DFT for identification of HDAC3 inhibitors for neurocognitive vascular dementia"],"prefix":"10.1038","volume":"15","author":[{"given":"Debojyoti","family":"Halder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvankar","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjan","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaram","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"28304_CR1","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1111\/jcmm.15358","volume":"24","author":"Y Fang","year":"2020","unstructured":"Fang, Y. et al. HDAC inhibitor protects chronic cerebral hypoperfusion and oxygen-glucose deprivation injuries via H3K14 and H4K5 acetylation-mediated BDNF expression. J. Cell. Mol. Med. 24, 6966\u20136977 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"28304_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41420-023-01399-w","volume":"9","author":"R He","year":"2023","unstructured":"He, R., Liu, B., Geng, B., Li, N. & Geng, Q. The role of HDAC3 and its inhibitors in regulation of oxidative stress and chronic diseases. Cell Death Discov. 9, 131 (2023).","journal-title":"Cell Death Discov."},{"key":"28304_CR3","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1111\/jcmm.16770","volume":"25","author":"Y Fang","year":"2021","unstructured":"Fang, Y. et al. HDACi protects against vascular cognitive impairment from CCH injury via induction of BDNF-related AMPA receptor activation. J. Cell. Mol. Med. 25, 7418\u20137425 (2021).","journal-title":"J. Cell. Mol. Med."},{"key":"28304_CR4","doi-asserted-by":"publisher","first-page":"110888","DOI":"10.1016\/j.brainresbull.2024.110888","volume":"208","author":"J Song","year":"2024","unstructured":"Song, J. et al. Baicalein ameliorates cognitive impairment of vascular dementia rats via suppressing neuroinflammation and regulating intestinal microbiota. Brain Res. Bull. 208, 110888 (2024).","journal-title":"Brain Res. Bull."},{"key":"28304_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1021\/acschemneuro.0c00721","volume":"12","author":"S Pulya","year":"2021","unstructured":"Pulya, S. et al. PT3: A novel benzamide class histone deacetylase 3 inhibitor improves learning and memory in novel object recognition mouse model. ACS Chem. Neurosci. 12, 883\u2013892 (2021).","journal-title":"ACS Chem. Neurosci."},{"key":"28304_CR6","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1080\/17501911.2024.2419357","volume":"16","author":"C Rosete","year":"2024","unstructured":"Rosete, C. & Ciernia, A. V. The two faces of HDAC3: Neuroinflammation in disease and neuroprotection in recovery. Epigenomics 16, 1373\u20131388 (2024).","journal-title":"Epigenomics"},{"key":"28304_CR7","doi-asserted-by":"publisher","first-page":"107481","DOI":"10.1016\/j.compbiomed.2023.107481","volume":"166","author":"G Lanka","year":"2023","unstructured":"Lanka, G. et al. Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors. Comput. Biol. Med. 166, 107481 (2023).","journal-title":"Comput. Biol. Med."},{"key":"28304_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41419-018-0543-8","volume":"9","author":"S Zhang","year":"2018","unstructured":"Zhang, S., Fujita, Y., Matsuzaki, R. & Yamashita, T. Class I histone deacetylase (HDAC) inhibitor CI-994 promotes functional recovery following spinal cord injury. Cell Death Dis. 9, 460 (2018).","journal-title":"Cell Death Dis."},{"key":"28304_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/jnc.12498","volume":"129","author":"SP Murphy","year":"2014","unstructured":"Murphy, S. P. et al. MS-275, a class I histone deacetylase inhibitor, protects the p53-deficient mouse against ischemic injury. J. Neurochem. 129, 509\u2013515 (2014).","journal-title":"J. Neurochem."},{"key":"28304_CR10","doi-asserted-by":"publisher","first-page":"e18160","DOI":"10.1016\/j.heliyon.2023.e18160","volume":"9","author":"H-P Gu","year":"2023","unstructured":"Gu, H.-P. et al. RGFP966 exerts neuroprotective effect via HDAC3\/Nrf2 pathway after surgical brain injury in rats. Heliyon 9, e18160 (2023).","journal-title":"Heliyon"},{"key":"28304_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2022.2050948","author":"D Halder","year":"2022","unstructured":"Halder, D., Das, S., Joseph, A. & Jeyaprakash, R. S. Molecular docking and dynamics approach to in silico drug repurposing for inflammatory bowels disease by targeting TNF alpha. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2022.2050948 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"28304_CR12","unstructured":"https:\/\/www.medchemexpress.com\/Targets\/HDAC\/hdac3.html. (2024)."},{"key":"28304_CR13","unstructured":"Schr\u00f6dinger Release 2022\u20134: Field-based QSAR, Schr\u00f6dinger, LLC, New York, (2021)"},{"key":"28304_CR14","unstructured":"Schr\u00f6dinger Release 2025\u20131: Phase, Schr\u00f6dinger, LLC, New York, 2025."},{"key":"28304_CR15","unstructured":"Schr\u00f6dinger Release 2023\u20133: LigPrep, Schr\u00f6dinger, LLC, New York, 2023."},{"key":"28304_CR16","doi-asserted-by":"publisher","first-page":"9403","DOI":"10.1039\/D0RA10168K","volume":"11","author":"S Zhao","year":"2021","unstructured":"Zhao, S. et al. Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists. RSC Adv. 11, 9403\u20139409 (2021).","journal-title":"RSC Adv."},{"key":"28304_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-023-10727-2","author":"D Halder","year":"2023","unstructured":"Halder, D., Das, S. & Jeyaprakash, R. S. Identification of natural product as selective PI3K\u03b1 inhibitor against NSCLC: Multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-023-10727-2 (2023).","journal-title":"Mol. Divers."},{"key":"28304_CR18","unstructured":"PerkinElmer Informatics, ChemDraw 22.0, Waltham, MA, USA, 2022."},{"key":"28304_CR19","unstructured":"PerkinElmer Informatics, Chem3D 22.0, Waltham, USA, 2022. at (2022)"},{"key":"28304_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.csbj.2019.02.006","volume":"17","author":"S Pal","year":"2019","unstructured":"Pal, S. et al. Ligand-based pharmacophore modeling, virtual screening and molecular docking studies for discovery of potential topoisomerase i inhibitors. Comput. Struct. Biotechnol. J. 17, 291\u2013310 (2019).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"28304_CR21","unstructured":"Accessed on Dec. 15th, 2024. https:\/\/www.chemdiv.com\/catalog\/focused-and-targeted-libraries\/cns-library\/."},{"key":"28304_CR22","unstructured":"Accessed on Dec. 15th, 2024. https:\/\/www.chemdiv.com\/catalog\/focused-and-targeted-libraries\/cns-bbb-library\/."},{"key":"28304_CR23","unstructured":"Accessed on Dec. 15th, 2024. https:\/\/www.chemdiv.com\/catalog\/focused-and-targeted-libraries\/epigenetics-focused-set\/."},{"key":"28304_CR24","unstructured":"Accessed on Dec. 15th, 2024. https:\/\/www.chemdiv.com\/catalog\/focused-and-targeted-libraries\/histone-deacetylases-hdac-targeted-library-selection\/."},{"key":"28304_CR25","unstructured":"Schr\u00f6dinger Release 2021\u20134: Protein Preparation Wizard; Epik, Schr\u00f6dinger, LLC, New York, NY, 2021; Impact, Schr\u00f6dinger, LLC, New York, Prime, Schr\u00f6dinger, LLC, New York, (2021)."},{"key":"28304_CR26","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. OPLS4: Improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17, 4291\u20134300 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"28304_CR27","unstructured":"https:\/\/www.uniprot.org\/uniprotkb\/Q803C3\/entry. 2024"},{"key":"28304_CR28","doi-asserted-by":"publisher","unstructured":"Structure of HDAC3 bound to corepressor and inositol tetraphosphate. https:\/\/doi.org\/10.2210\/pdb4a69\/pdb (2012)","DOI":"10.2210\/pdb4a69\/pdb"},{"key":"28304_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature10728","volume":"481","author":"PJ Watson","year":"2012","unstructured":"Watson, P. J., Fairall, L., Santos, G. M. & Schwabe, J. W. R. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature 481, 335\u2013340 (2012).","journal-title":"Nature"},{"key":"28304_CR30","unstructured":"Schr\u00f6dinger Release 2025\u20131: Protein Preparation Workflow; Epik, Schr\u00f6dinger, LLC, New York, 2024; Impact, Schr\u00f6dinger, LLC, New York, Prime, Schr\u00f6dinger, LLC, New York, (2025)."},{"key":"28304_CR31","doi-asserted-by":"publisher","first-page":"12033","DOI":"10.1021\/acs.jmedchem.3c00614","volume":"66","author":"S Pulya","year":"2023","unstructured":"Pulya, S. et al. Selective HDAC3 inhibitors with potent in vivo antitumor efficacy against triple-negative breast cancer. J. Med. Chem. 66, 12033\u201312058 (2023).","journal-title":"J. Med. Chem."},{"key":"28304_CR32","unstructured":"Schr\u00f6dinger Release 2023\u20131: Glide, Schr\u00f6dinger, LLC, New York, (2021)"},{"key":"28304_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2023.2300131","author":"S Das","year":"2024","unstructured":"Das, S., Halder, D. & Jeyaprakash, R. S. Computational-guided approach for identification of PI3K alpha inhibitor in the treatment of hepatocellular carcinoma by virtual screening and water map analysis. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2023.2300131 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"28304_CR34","unstructured":"Schr\u00f6dinger Release 2023\u20131: Prime, Schr\u00f6dinger, LLC, New York, (2021)"},{"key":"28304_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11030-024-10837-5","volume":"29","author":"G Lanka","year":"2025","unstructured":"Lanka, G., Banerjee, S., Adhikari, N. & Ghosh, B. Fragment-based discovery of new potential DNMT1 inhibitors integrating multiple pharmacophore modeling, 3D-QSAR, virtual screening, molecular docking, ADME, and molecular dynamics simulation approaches. Mol. Divers. 29, 117\u2013137 (2025).","journal-title":"Mol. Divers."},{"key":"28304_CR36","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1021\/acs.chemrestox.0c00450","volume":"34","author":"CK Jaladanki","year":"2021","unstructured":"Jaladanki, C. K., Khatun, S., Gohlke, H. & Bharatam, P. V. Reactive metabolites from thiazole-containing drugs: Quantum chemical insights into biotransformation and toxicity. Chem. Res. Toxicol. 34, 1503\u20131517 (2021).","journal-title":"Chem. Res. Toxicol."},{"key":"28304_CR37","unstructured":"Schr\u00f6dinger Release 2022\u20134: Jaguar, Schr\u00f6dinger, LLC, New York, (2021)"},{"key":"28304_CR38","unstructured":"Schr\u00f6dinger Release 2021\u20134: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2021. Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, (2021)."},{"key":"28304_CR39","doi-asserted-by":"publisher","first-page":"21452","DOI":"10.1039\/D2RA03451D","volume":"12","author":"D Halder","year":"2022","unstructured":"Halder, D. & Das, S. Molecular docking and dynamics based approach for the identification of kinase inhibitors targeting PI3K\u03b1 against non-small cell lung cancer: A computational study. RSC Adv. 12, 21452\u201321467 (2022).","journal-title":"RSC Adv."},{"key":"28304_CR40","unstructured":"Origin(Pro), Version 2025, OriginLab Corporation, Northampton, USA."},{"key":"28304_CR41","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).","journal-title":"Sci. Rep."},{"key":"28304_CR42","unstructured":"Schr\u00f6dinger Release 2021\u20134: QikProp, Schr\u00f6dinger, LLC, New York, (2021)"},{"key":"28304_CR43","unstructured":"Schr\u00f6dinger Release 2023\u20133: QikProp, Schr\u00f6dinger, LLC, New York, (2023)."},{"key":"28304_CR44","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"DEV Pires","year":"2015","unstructured":"Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"28304_CR45","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s11224-020-01714-6","volume":"32","author":"SK Verma","year":"2021","unstructured":"Verma, S. K., Kumar, N. & Thareja, S. Gaussian field-based comparative 3D QSAR modelling for the identification of favourable pharmacophoric features of chromene derivatives as selective inhibitors of ALR2 over ALR1. Struct. Chem. 32, 1289\u20131298 (2021).","journal-title":"Struct. Chem."},{"key":"28304_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1747-0285.2007.00606.x","volume":"71","author":"NK Salam","year":"2007","unstructured":"Salam, N. K. et al. Novel PPAR-gamma agonists identified from a natural product library: A virtual screening, induced-fit docking and biological assay study. Chem. Biol. Drug Des. 71, 57\u201370 (2007).","journal-title":"Chem. Biol. Drug Des."},{"key":"28304_CR47","doi-asserted-by":"publisher","first-page":"105446","DOI":"10.1016\/j.bioorg.2021.105446","volume":"117","author":"G Routholla","year":"2021","unstructured":"Routholla, G. et al. Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model. Bioorg. Chem. 117, 105446 (2021).","journal-title":"Bioorg. Chem."},{"key":"28304_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2174\/2589977511666190912154817","volume":"11","author":"R Kalirajan","year":"2019","unstructured":"Kalirajan, R., Pandiselvi, A., Gowramma, B. & Balachandran, P. In-silico design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer. Curr. Drug Res. Rev. 11, 118\u2013128 (2019).","journal-title":"Curr. Drug Res. Rev."},{"key":"28304_CR49","unstructured":"Schr\u00f6dinger Release 2023\u20133: Prime, Schr\u00f6dinger, LLC, New York, (2023)."},{"key":"28304_CR50","unstructured":"Schr\u00f6dinger Release 2023\u20133: Induced Fit Docking protocol; Glide, Schr\u00f6dinger, LLC, New York, NY, 2023; Prime, Schr\u00f6dinger, LLC, New York, (2023)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28304-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28304-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:31:28Z","timestamp":1777113088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-28304-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["28304"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-28304-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]},"assertion":[{"value":"13 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44561"}}